Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A cross-reactive idiotype in scleroderma

D Vázquez-Abad1, L Tian, M Zanetti

  • 1Department of Medicine, University of Connecticut School of Medicine, Farmington 06030-1310, USA.

Clinical and Experimental Immunology
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma pTau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease.

medRxiv : the preprint server for health sciences·2026
Same author

[Experimental study on interleukin-10 secretion from M2 macrophages promoting osteogenic differentiation of rat bone marrow mesenchymal stem cells post-radiation].

Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology·2026
Same author

[Analysis of challenges in the surgical management of gallbladder neoplasms].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2026
Same author

[Chinese dentists in the War to Resist US Aggression and Aid Korea].

Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology·2026
Same author

Measurement of Reactor Antineutrino Oscillation at SNO.

Physical review letters·2025
Same author

Association of unexplained recurrent implantation failure with obstetric and neonatal outcomes: cohort study of 37 888 singleton live births.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Same journal

The many faces of cytokine storm syndrome: immunopathogenic mechanisms and clinical implications for a better patient management.

Clinical and experimental immunology·2026
Same journal

PD-1 Engagement and Circulating Th17 Effector Activity During Secukinumab Treatment in Plaque Psoriasis.

Clinical and experimental immunology·2026
Same journal

Henoch-Schoenlein purpura (HSP) like lesions in IL12RB1 and IL12B defects - A multi-centric experience from India.

Clinical and experimental immunology·2026
Same journal

Case Series on the Efficacy of Daratumumab in Treating Patients with Anti-Interferon-Gamma Autoantibodies.

Clinical and experimental immunology·2026
Same journal

Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function.

Clinical and experimental immunology·2026
Same journal

Clinical, genetic, and functional characterization of novel NFKB1 variants in Chinese patients with primary immunodeficiency.

Clinical and experimental immunology·2026
See all related articles

Researchers identified a common idiotype (Id-EM) in scleroderma autoantibodies, including anti-centromere proteins (anti-CENPs) and anti-topoisomerase-I. This cross-reactive idiotype was also found in scleroderma patients lacking these specific autoantibodies, suggesting a shared structural feature in scleroderma pathogenesis.

Area of Science:

  • Immunology
  • Rheumatology
  • Molecular Biology

Background:

  • Autoantibodies to centromere proteins (anti-CENPs) and topoisomerase-I are highly specific markers for scleroderma.
  • These scleroderma-specific autoantibodies are typically mutually exclusive in patients.
  • Understanding shared features of autoantibodies can provide insights into disease mechanisms.

Purpose of the Study:

  • To investigate the idiotypes (Ids) of anti-CENP-B and anti-topoisomerase-I autoantibodies in scleroderma patients.
  • To determine if a common idiotype exists among different scleroderma-associated autoantibodies.
  • To explore the presence of this idiotype in scleroderma patients lacking these specific autoantibodies.

Main Methods:

  • Preparation of rabbit anti-idiotype antibodies against anti-topoisomerase-I and anti-CENP-B from scleroderma patients.

Related Experiment Videos

  • Analysis of purified autoantibodies and immunoglobulins from scleroderma patients, SLE patients, and healthy controls using ELISAs and immunoblots.
  • Direct binding and competitive inhibition assays to identify and characterize idiotypes.

    • Main Results:

    • A cross-reactive idiotype (Id-EM) was identified in the heavy chains of affinity-purified anti-topoisomerase-I and anti-CENP-B autoantibodies.
    • This Id-EM was also present in immunoglobulins of scleroderma patients who were negative for both anti-topoisomerase-I and anti-CENP-B.
    • The Id-EM was not detected in patients with systemic lupus erythematosus (SLE) or in normal healthy controls.
    • The identified cross-reactive idiotype was stable over time in samples from individual patients.

    Conclusions:

    • Scleroderma-specific autoantibodies, including anti-topoisomerase-I and anti-CENP-B, share a common structural feature (Id-EM) in their variable heavy chain regions.
    • This cross-reactive idiotype may serve as a disease-specific marker for scleroderma, even in the absence of classical autoantibodies.
    • The findings suggest a potential common origin or structural basis for autoantibody production in scleroderma.